My Size Financials
My Size (MYSZ) reported $9.4M in revenue for fiscal year 2025, up 13.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported profit is being driven outside operations while the core business remains cash-consuming and increasingly dependent on financing.
The split between a positive net result of$5.9M in FY2025 and operating cash flow of-$5.1M indicates that reported earnings are not being converted by recurring operations. The same pattern appeared in FY2024: net income was$4.0M while operating cash flow was-$3.1M , making cash conversion more informative than headline profit.
Revenue reached
Financing supplied
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of My Size's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
My Size has an operating margin of -61.3%, meaning the company loses $61 on every $100 of revenue. This results in a profitability score of 22/100. This is down from -47.8% the prior year.
My Size's revenue grew 13.4% year-over-year to $9.4M, a solid pace of expansion. This earns a growth score of 77/100.
My Size carries a low D/E ratio of 0.16, meaning only $0.16 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 77/100, indicating a strong balance sheet with room for future borrowing.
My Size's current ratio of 1.87 indicates adequate short-term liquidity, earning a score of 54/100. The company can meet its near-term obligations, though with limited headroom.
My Size's operations used $5.1M of cash, and capex of $16K added to the outflow, for a free cash flow shortfall of $5.2M. This results in a cash flow score of 8/100.
My Size generates a 113.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 24/100. This is up from 57.8% the prior year.
My Size scores -9.88, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.7M) relative to total liabilities ($5.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
My Size passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, My Size used $0.88 of operating cash (-$5.1M OCF vs $5.9M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
My Size generated $9.4M in revenue in fiscal year 2025. This represents an increase of 13.4% from the prior year.
My Size's EBITDA was -$5.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 48.7% from the prior year.
My Size reported $5.9M in net income in fiscal year 2025. This represents an increase of 46.5% from the prior year.
Cash & Balance Sheet
My Size recorded an outflow of $5.2M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 66.4% from the prior year.
My Size held $2.3M in cash against $831K in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
My Size's gross margin was 32.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 8.2 percentage points from the prior year.
My Size's operating margin was -61.3% in fiscal year 2025, reflecting core business profitability. This is down 13.5 percentage points from the prior year.
My Size's net profit margin was 62.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 14.1 percentage points from the prior year.
My Size's ROE was 113.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 55.7 percentage points from the prior year.
Capital Allocation
My Size invested $597K in research and development in fiscal year 2025. This represents an increase of 39.2% from the prior year.
My Size invested $16K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 128.6% from the prior year.
Not reported for fiscal year 2025.
MYSZ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY10 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1M | $9.4M+13.4% | $8.3M+18.0% | $7.0M+56.9% | $4.5M+3303.8% | $131K-7.7% | $142K+125.4% | $63K | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | $6.4M+28.9% | $4.9M+15.7% | $4.3M+11.5% | $3.8M | N/A | $2K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $3.0M-9.7% | $3.3M+21.7% | $2.7M+330.8% | $634K+384.0% | $131K-6.4% | $140K+233.3% | $42K | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | $597K+39.2% | $429K-56.0% | $974K-42.7% | $1.7M-60.0% | $4.2M+178.9% | $1.5M+0.5% | $1.5M+37.2% | $1.1M+30.8% | $845K+16.2% | $727K+141.5% | $301K+285.9% | $78K | N/A |
| SG&A Expenses | N/A | $4.8M+42.1% | $3.4M-15.2% | $4.0M+1.8% | $3.9M-5.4% | $4.1M+60.7% | $2.6M-0.8% | $2.6M-18.4% | $3.2M | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | -$5.7M-45.5% | -$3.9M+41.5% | -$6.7M+16.9% | -$8.1M+23.3% | -$10.6M-72.1% | -$6.1M-2.6% | -$6.0M-15.7% | -$5.2M+7.8% | -$5.6M-116.9% | -$2.6M-36.5% | -$1.9M-185.4% | -$664K | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $6K | N/A |
| Income Tax | N/A | N/A | N/A | -$333K-825.0% | -$36K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | $5.9M+46.5% | $4.0M+162.6% | -$6.4M+23.2% | -$8.3M+21.0% | -$10.5M-70.9% | -$6.2M-12.0% | -$5.5M+7.9% | -$6.0M-10.5% | -$5.4M-24.7% | -$4.3M-26.1% | -$3.4M-634.4% | -$468K | N/A |
| EPS (Diluted) | — | -$1.87 | -$4.39 | -$20.40 | -$7.47 | N/A | -$1.11 | -$3.12 | -$3.03 | -$0.30-11.1% | -$0.27 | N/A | N/A | N/A |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
No annual filing on record for: FY2011, FY2012, FY2013.
MYSZ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY10 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.2M+1.4% | $10.1M+11.9% | $9.0M-7.6% | $9.7M-22.5% | $12.6M+252.2% | $3.6M+20.6% | $3.0M-58.4% | $7.1M+194.3% | $2.4M+12.5% | $2.1M-42.5% | $3.7M+379.8% | $779K | $82K |
| Current Assets | $7.7M-14.7% | $9.1M+36.9% | $6.6M+9.4% | $6.1M-47.6% | $11.6M+368.5% | $2.5M+35.2% | $1.8M-73.3% | $6.8M+203.5% | $2.3M+50.5% | $1.5M-59.3% | $3.7M+387.0% | $755K | $82K |
| Cash & Equivalents | $2.3M-52.8% | $4.9M+123.1% | $2.2M+4.1% | $2.1M-80.3% | $10.7M+531.7% | $1.7M+40.4% | $1.2M-76.6% | $5.1M+185.2% | $1.8M+5200.0% | $34K-96.3% | $919K+42.5% | $645K | $33K |
| Inventory | $3.0M+8.5% | $2.8M-2.9% | $2.9M+188.8% | $997K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $1.2M+336.7% | $278K-54.8% | $615K-68.3% | $1.9M+4750.0% | $40K+42.9% | $28K-26.3% | $38K | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $640K+381.2% | $133K-82.5% | $758K-45.7% | $1.4M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $5.0M+60.2% | $3.1M-26.0% | $4.3M-18.0% | $5.2M+205.2% | $1.7M+14.2% | $1.5M-21.9% | $1.9M+4.6% | $1.8M-48.9% | $3.6M+471.2% | $625K-90.2% | $6.4M+2010.0% | $301K | $2.0M |
| Current Liabilities | $4.1M+37.9% | $3.0M-22.7% | $3.9M-7.2% | $4.2M+240.3% | $1.2M+34.8% | $911K-27.0% | $1.2M-31.5% | $1.8M-48.9% | $3.6M+471.2% | $625K-90.2% | $6.4M+2010.0% | $301K | $2.0M |
| Long-Term Debt | $831K+469.2% | $146K-41.4% | $249K-33.8% | $376K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $5.2M-25.4% | $6.9M+45.9% | $4.7M+4.4% | $4.5M-58.2% | $10.9M+423.0% | $2.1M+97.5% | $1.1M-80.1% | $5.3M+559.5% | -$1.2M-175.5% | $1.5M+158.4% | -$2.6M-646.7% | $478K | -$1.9M |
| Retained Earnings | -$69.7M-9.2% | -$63.9M-6.7% | -$59.9M-11.9% | -$53.5M-18.4% | -$45.2M-30.3% | -$34.7M-21.6% | -$28.5M-23.9% | -$23.0M-35.0% | -$17.0M-46.4% | -$11.6M-59.3% | -$7.3M-88.7% | -$3.9M | -$184.4M |
No annual filing on record for: FY2011, FY2012, FY2013.
MYSZ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY10 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$4.9M | -$5.1M-66.3% | -$3.1M+49.4% | -$6.1M+16.2% | -$7.3M+0.1% | -$7.3M-28.5% | -$5.7M-4.8% | -$5.4M-50.6% | -$3.6M+13.1% | -$4.1M-91.8% | -$2.2M-50.0% | -$1.4M-96.3% | -$733K | N/A |
| Capital Expenditures | $47K | $16K+128.6% | $7K0.0% | $7K-74.1% | $27K+17.4% | $23K+43.8% | $16K-84.5% | $103K+157.5% | $40K+150.0% | $16K-55.6% | $36K-23.4% | $47K | N/A | N/A |
| Free Cash Flow | -$4.9M | -$5.2M-66.4% | -$3.1M+49.3% | -$6.1M+16.5% | -$7.3M0.0% | -$7.3M-28.5% | -$5.7M-3.2% | -$5.5M-51.8% | -$3.6M+12.5% | -$4.2M-89.3% | -$2.2M-47.7% | -$1.5M | N/A | N/A |
| Investing Cash Flow | -$189K | -$196K-469.8% | $53K+857.1% | -$7K+99.3% | -$993K-716.8% | $161K+176.3% | -$211K-119.7% | $1.1M+175.5% | -$1.4M-8781.3% | -$16K+55.6% | -$36K | N/A | N/A | $59K |
| Financing Cash Flow | $1.3M | $3.0M-46.5% | $5.6M-8.8% | $6.1M+9255.2% | -$67K-100.4% | $16.3M+167.3% | $6.1M+2191.0% | $266K-97.1% | $9.0M+52.4% | $5.9M+351.4% | $1.3M | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
No annual filing on record for: FY2011, FY2012, FY2013.
MYSZ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY10 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.0%-8.2pp | 40.2%+1.2pp | 39.0%+24.8pp | 14.2%-85.8pp | 100.0%+1.4pp | 98.6%+31.9pp | 66.7% | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -61.3%-13.5pp | -47.8%+48.6pp | -96.4% | -181.9% | -8074.0% | -4328.2% | -9507.9% | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 62.5%+14.1pp | 48.4%+139.6pp | -91.2% | -186.4% | -8030.5% | -4335.9% | -8725.4% | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | 113.5%+55.7pp | 57.8%+192.6pp | -134.7%+48.5pp | -183.2%-86.3pp | -96.9%+199.7pp | -296.6%+226.4pp | -523.0%-410.3pp | -112.8% | N/A | -284.2% | N/A | -97.9% | N/A |
| Return on Assets | 57.4%+17.6pp | 39.7%+110.7pp | -71.0%+14.5pp | -85.4%-1.7pp | -83.8%+88.9pp | -172.7%+13.2pp | -185.8%-102.0pp | -83.9%+139.6pp | -223.5%-21.9pp | -201.6%-109.6pp | -92.0%-31.9pp | -60.1% | N/A |
| Current Ratio | 1.87-1.2x | 3.03+1.3x | 1.71+0.3x | 1.45-8.0x | 9.42+6.7x | 2.71+1.2x | 1.46-2.3x | 3.75+3.1x | 0.63-1.8x | 2.40+1.8x | 0.58-1.9x | 2.51 | 0.04 |
| Debt-to-Equity | 0.16+0.1x | 0.020.0x | 0.050.0x | 0.08-0.1x | 0.16-0.6x | 0.72-1.1x | 1.81+1.5x | 0.34 | N/A | 0.41 | N/A | 0.63 | N/A |
| FCF Margin | -55.1%-17.6pp | -37.5%+49.9pp | -87.4% | -164.1% | -5587.8% | -4010.6% | -8763.5% | N/A | N/A | N/A | N/A | N/A | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
No annual filing on record for: FY2011, FY2012, FY2013.
Similar Companies
Where My Size Ranks
Frequently Asked Questions
What is My Size's annual revenue?
My Size (MYSZ) reported $9.4M in total revenue for fiscal year 2025. This represents a 13.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is My Size's revenue growing?
My Size (MYSZ) revenue grew by 13.4% year-over-year, from $8.3M to $9.4M in fiscal year 2025.
Is My Size profitable?
Yes, My Size (MYSZ) reported a net income of $5.9M in fiscal year 2025, with a net profit margin of 62.5%.
What is My Size's EBITDA?
My Size (MYSZ) had EBITDA of -$5.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does My Size have?
As of fiscal year 2025, My Size (MYSZ) had $2.3M in cash and equivalents against $831K in long-term debt.
What is My Size's gross margin?
My Size (MYSZ) had a gross margin of 32.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is My Size's operating margin?
My Size (MYSZ) had an operating margin of -61.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is My Size's net profit margin?
My Size (MYSZ) had a net profit margin of 62.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is My Size's return on equity (ROE)?
My Size (MYSZ) has a return on equity of 113.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is My Size's free cash flow?
My Size (MYSZ) recorded an outflow of $5.2M in free cash flow during fiscal year 2025. This represents a -66.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is My Size's operating cash flow?
My Size (MYSZ) recorded an outflow of $5.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are My Size's total assets?
My Size (MYSZ) had $10.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are My Size's capital expenditures?
My Size (MYSZ) invested $16K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does My Size spend on research and development?
My Size (MYSZ) invested $597K in research and development during fiscal year 2025.
What is My Size's current ratio?
My Size (MYSZ) had a current ratio of 1.87 as of fiscal year 2025, which is generally considered healthy.
What is My Size's debt-to-equity ratio?
My Size (MYSZ) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is My Size's return on assets (ROA)?
My Size (MYSZ) had a return on assets of 57.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does My Size's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, My Size (MYSZ) held $2.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $5.1M over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is My Size's Altman Z-Score?
My Size (MYSZ) has an Altman Z-Score of -9.88, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is My Size's Piotroski F-Score?
My Size (MYSZ) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are My Size's earnings high quality?
For every $1 of reported earnings, My Size (MYSZ) used $0.88 of operating cash (-$5.1M OCF vs $5.9M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is My Size?
My Size (MYSZ) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.